Skip to main content

Table 2 Basic patient characteristics

From: Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study

Age, median (range)

 

58 (18–81)

Gender, N (%)

F

68 (55)

M

55 (45)

Stage, N (%)

I

12 (10)

II

41 (34)

III

30 (24)

IV

39 (32)

Missing

1

IPI, N (%)

0

23 (19)

1

36 (29)

2

27 (22)

3

20 (16)

4

13 (11)

5

4 (3)

Treatment response according to international criteria, N (%)

CR

102 (83)

PR

18 (15)

SD

2 (2)

PD

0 (0)

Missing

1

Combined metabolic and morphologic responses, N (%)

Complete metabolic and morphologic response

68 (59)

Complete metabolic response with residual mass

24 (21)

Partial metabolic response with residual mass

23 (20)

Missing

8

Collecting institutions, N (%)

University hospitals

33 (27)

Other hospitals

90 (73)